Harvard Bioscience Inc HBIO
$8.03
-1.47%
at last close
Financials (TTM)
- Revenue
- $87.81 million
- Net Income
- $-10,412,000
- Net Margin
- -11.86%
- Return on Equity
- -140.36%
- Debt-to-Equity
- 4.94
- P/E Ratio
- —
- Price / Book
- 4.93
- Price / Sales
- 0.42
Over the trailing twelve months, Harvard Bioscience Inc generated revenue of $87.81 million and net income of $-10,412,000, a net margin of -11.86%.
At the last closing price of $8.03, HBIO trades at 0.42 times sales, with a market capitalization of $36.56 million.
Key Stats
- Last Close
- $8.03
- Market Cap
- $36.56 million
- 52-Week Range
- $3.75 – $9.40
- Average Volume
- 21K shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.